← Browse by Condition
Medical Condition

hypocalcemia

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for hypocalcemia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — hypocalcemia Clinical Trials

How many clinical trials are currently recruiting for hypocalcemia?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for hypocalcemia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hypocalcemia?
hypocalcemia research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hypocalcemia clinical trial?
Eligibility criteria for hypocalcemia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
University of Wuerzburg 1 trial
Hôpital NOVO 1 trial
Tseung Kwan O Hospital, Hong Kong 1 trial

Recruiting Clinical Trials

NCT05585593
Recruiting
Registry for Hypoparathyroidism Wuerzburg
Enrollment
300 pts
Location
Germany
Sponsor
University of Wuerzburg
View Trial →
NCT04775381 Phase 3
Recruiting
Total Post-thyroidectomy Hypocalcemia After Preoperative Cholecalciferol Supplementation
Enrollment
200 pts
Location
France
Sponsor
Hôpital NOVO
View Trial →
NCT05732883 Phase 2
Recruiting
The Use of Dexamethasone in Total Thyroidectomy to Improve Voice Outcome and Hypocalcaemia
Enrollment
100 pts
Location
Hong Kong
Sponsor
Tseung Kwan O Hospital, Hong K...
View Trial →

Related Conditions

comorbidities and coexisting conditions (1) morality (1) hypercalcemia (1) quality of life (1) voice change (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology